Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

July 26, 2024
Vol.50 No.30
NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

July 12, 2024
Vol.50 No.28
By Paul Goldberg
High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

June 28, 2024
Vol.50 No.26
By McKenzie Prillaman
NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

June 28, 2024
Vol.50 No.26
By Matthew Bin Han Ong
Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
FreeObituary

Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82

June 28, 2024
Vol.50 No.26
By Jacquelyn Cobb
BSA approves five new, 17 reissue concepts

BSA approves five new, 17 reissue concepts

June 28, 2024
Vol.50 No.26
By McKenzie Prillaman
Edward Sondik on his beginnings in public health, cancer prevention, and a “battlefield promotion”
FreeIn the Archives

Edward Sondik on his beginnings in public health, cancer prevention, and a “battlefield promotion”

June 28, 2024
Vol.50 No.26
House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Capitol Hill

House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research

June 21, 2024
Vol.50 No.25
By Matthew Bin Han Ong
Clinical Roundup

Combination targeted treatment produces lasting remissions in resistant aggressive DLBCL in phase Ib/II study

June 21, 2024
Vol.50 No.25
NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines
NCI

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

June 14, 2024
Vol.50 No.24
By Matthew Bin Han Ong

Posts navigation

Previous1…141516…37Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account